Author

W. F. Elmquist

Observed names: WF Elmquist, William Elmquist, William F. Elmquist

Institution: University of Minnesota

Observed institutions: University of Minnesota, Mayo Clinic

OpenAlex ID: A5060620360

Improving drug delivery to primary and metastatic brain tumors: Strategies to overcome the blood–brain barrier

2015 · KE Parrish, JN Sarkaria, et al. · Clinical Pharmacology & Therapeutics · 131

Decreased affinity for efflux transporters increases brain penetrance and molecular targeting of a PI3K/mTOR inhibitor in a mouse model of glioblastoma

2015 · C. M. Becker, R. K. Oberoi, et al. · Neuro-Oncology · 41

Factors Influencing the Central Nervous System Distribution of a Novel Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GSK2126458: Implications for Overcoming Resistance with Combination Therapy for Melanoma Brain Metastases

2015 · Shruthi Vaidhyanathan, Brynna Wilken-Resman, et al. · Journal of Pharmacology and Experimental Therapeutics · 20

Rmtc-03 Evaluating “brain Permeability”: a Critical Issue for the Development of Therapeutic Agents to Reduce the Incidence of Brain Metastases

2026 · Stuart Grossman, Amy Barone, et al. · Neuro-Oncology Advances · 1

High Grade Gliomas and Dipg

2014 · C. F. Classen, D. William, et al. · Neuro-Oncology · 1

Preclinical Experimental Therapeutics and Pharmacology

2011 · H. Pavel, N. Ajeawung, et al. · Neuro-Oncology · 1

Influence of Drug Delivery on Therapeutic Benefit in Gbm-cdk4 and Mdm2 Inhibitor Comparison in Flank Versus Orthotopic Models and Comparison of Brain Penetrant Versus Impenetrant Pi3k/mtor Inhibitors

2014 · J. N. Sarkaria, J. L. Pokorny, et al. · Neuro-Oncology

Works count: 9

Citation count: 197

H-index: 3

I10-index: 3